We previously generated a cell-culture based model of dasatinib resistance using the human pre-BCR+/E2A-PBX1+ ALL cell line RCH-ACV, which has been used to study mechanisms of resistance to targeted therapy in this genetic ALL subtype [12]. The gene discussed is PBX1; the disease is acute lymphoblastic leukemia.